We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
This new facility significantly increases the company’s footprint for secondary packaging, storage, logistics, and distribution of clinical supplies to investigator sites across Europe. Featuring highly automated technology in a fully scalable, mixed-use space, the site will serve as a strategic logistics hub for shipping by road or air and its central location will help expedite clinical trial therapies to patients.
Download the site capabilities fact sheet for more information.